Interview with the CEO of Synthetic Biologics, Jeff Riley

February 8, 2016- Interviewed by Steven E. Greer, MD

We spoke with Jeff Riley, the CEO of Synthetic Biologics, about the importance of the microbiome to our intestinal health.

This entry was posted in - Biotech, Gastroenterology and liver, Infectious disease, NIH. Bookmark the permalink.

Leave a Reply